MIZUHO SECURITIES USA LLC
Broker-DealerPosition in TCRX — TScan Therapeutics, Inc.
CIK 812291
NEW YORK, NY
Position in TCRX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$201,488
+$191,488 QoQ
Shares Held
205,600
+1956.0% QoQ
Ownership
0.315%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 4 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MIZUHO SECURITIES USA LLC holds $19,355,535 across 8 Biotechnology names. TCRX ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,870 | $9,870,025 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,823 | $4,877,953 | |
| 3 | MRNA |
Moderna, Inc.
|
27,647 | $1,936,119 | |
| 4 | INCY |
Incyte Corp
|
13,138 | $1,489,323 | |
| 5 | TECH |
BIO-TECHNE Corp
|
12,258 | $866,027 | |
| 6 | TCRX |
TScan Therapeutics, Inc.
This page
|
205,600 | $201,488 | |
| 7 | VSTM |
Verastem, Inc.
|
30,000 | $114,600 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
11,083 | $0 |
All Filings in TCRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $201,488 | 205,600 | Shares | Defined | 2026-07-28 | |
| 2025-12-31 | $10,000 | 10,000 | Shares | Defined | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||